Shrikant Mukewar

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force.

Uday C. Ghoshal, Philip Abraham, Chetan Bhatt et al. · PubMed · 2008 · 189 citations

Colon Tuberculosis: Endoscopic Features and Prospective Endoscopic Follow-Up After Anti-Tuberculosis Treatment

Saurabh Mukewar, Shrikant Mukewar, Raghvendra Ravi et al. · Clinical and Translational Gastroenterology · 2012 · 111 citations · Full text

Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: Report of the Indian Society of Gastroenterology Task Force

Shobna Bhatia, D. Nageshwar Reddy, Uday C. Ghoshal et al. · Indian Journal of Gastroenterology · 2011 · 103 citations

Gastroenterology Task Force, Esophagus, Indian Society +7

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Geert D’Haens, Vipul Jairath et al. · The Lancet · 2024 · 76 citations

Moderately-to-severely Active Crohn, Immunology, Gastroenterology +5